Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)

BACKGROUND: Statins have been proved to be effective in reduction of mortality and morbidity when started in the early secondary prevention in stabilized patients after acute coronary syndrome (ACS). The safety and efficacy of statin administration directly in the first-line therapy in unstable ACS...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ostadal, Petr, Alan, David, Vejvoda, Jiri, Kukacka, Jiri, Macek, Milan, Hajek, Petr, Mates, Martin, Kvapil, Milan, Kettner, Jiri, Wiendl, Martin, Aschermann, Ondrej, Slaby, Josef, Holm, Frantisek, Telekes, Peter, Horak, David, Blasko, Peter, Zemanek, David, Veselka, Josef, Cepova, Jana
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2010
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2886041/
https://ncbi.nlm.nih.gov/pubmed/20500832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-11-61
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki